Drugs developed with the assistance of public funding would be vulnerable to government price controls and patent seizures if Biden succeeds in implementing an unprecedented expansion of an authority originally created in 1980.
The $1.7 trillion Build Back Better Act’s drug pricing reforms could reduce American lifespans and reduce creation of new drugs, according to a study.
A drug pricing provision in the $3.5 trillion reconciliation package currently making its way through Congress could derail the entire package, and Rep. Andy Kim (D-NJ) is one of two New Jersey Democrats facing pressure from within the Garden State to break with the party and oppose the provision.
Democrats’ efforts to reform drug pricing in the $3.5 trillion infrastructure have increasingly fractured the party.
President Joe Biden’s first actions included a directive that suspends President Donald Trump’s executive order aimed at lowering the prices of insulin and epinephrine, which was to have gone into effect on Friday, January 22.
President Donald Trump has lowered drug prices and issued several executive orders on lowering Medicare drug prices, though critics say more action is needed.
The fact is that drug prices have fallen under President Donald Trump for the first time in nearly half a century.
The Congressional Budget Office (CBO) released an analysis on Friday that found that Senate Finance Committee Chairman Chuck Grassley (R-IA) and Ranking Member Ron Wyden’s (D-OR) drug pricing bill would cut spending by $95 billion, reduce out-of-pocket spending, and reduce premiums.
A group of Democratic Party legislators disrupted President Donald Trump’s State of the Union address on Tuesday evening by thrusting three fingers into the air and chanting, “H.R. 3!”. H.R. 3 is the “Elijah E. Cummings Lower Drug Costs Now
Fact check – CLAIM: Americans are paying more for prescription drugs than they did a decade ago, CNN’s Wolf Blitzer said. VERDICT: Incomplete. Prescription drug prices also fell last year for the first time in nearly half a century.
Democrat entrepreneur Andrew Yang is a long shot to win the White House in 2020, but he is still rolling out his presidential plans, including more federal government control over the medical prescription industry.
Joe Biden struggled to name the department of Health and Human Services, while discussing his proposal to expand Obamacare and lower drug prices.
President Trump already has significant achievements on health care that can be summarized as follows: more choice, lower prices, life-saving drugs.
In his second State of the Union address, President Donald Trump offered a path forward for a divided nation–unifying even his fiercest critics behind at least some of what he is trying to do.
California Governor Gavin Newsom’s first act in office was to propose extending state healthcare benefits to more illegal aliens.
The First Step Act could be the beginning of a joint effort to address challenges that have ready solutions but that, because of their political difficulty, need bipartisan support to pass.
As the Trump administration pushes for drug price transparency, the pharmaceutical industry is already trying to subvert the coming changes.
President Donald Trump is scheduled to participate in a signing ceremony Wednesday afternoon for two bills related to drug prices: Know the Lowest Price Act and Patients Right to Know Drug Prices Act.
Major U.S. drug manufacturer Pfizer agreed to roll back July 1 drug price hikes after an “extensive discussion” with President Donald Trump on Tuesday.
During Friday’s Democratic Weekly Address, Senator Debbie Stabenow (D-MI) discussed prescription drug prices and argued Republicans should join Democrats in taking action to lower drug prices. Transcript as Follows: “Today, President Trump is scheduled to speak about the need to
“We will have tougher negotiation, more competition, and much lower prices at the pharmacy counter and it will start to take effect very soon,” Trump said.
